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ABSTRACT
Dot-ELISA using the outer membrane complex antigens of Neisseria meningitidis as a target was 
standardized for rapid detection of meningococcal-specific antibodies in human serum. We inves-
tigated the level of meningococcal-specific IgG, IgA, and IgM in serum using dot-ELISA with outer 
membrane antigens prepared from Neisseria meningitidis serotype B:4.19:P1.15,3,7,9 (a strain iso-
lated from a Brazilian epidemic). The dot-ELISA is based on the same principles as the standard 
ELISA and is useful for detection of anti-N. meningitidis B antibodies in serum of patients with 
meningococcal infections. For the assay, outer membrane complexes (OMCs) were absorbed by 
nitrocellulose membrane and blocked with a 5% skim milk solution. Serum samples were drawn 
upon hospital admission and during convalescence from patients with meningococcal septicemia, 
and single samples were drawn from uninfected controls. We retrospectively examined a total of 
57 serum samples: 35 from patients infected with N. meningitidis B, 12 from patients infected with 
Haemophilus influenzae b, and 10 from health individuals. When performed at room temperature, 
dot-ELISA took approximately four hours to perform, and the optimum antigen concentration was 
0.42 μg per dot. The specificity of IgG, IgM, and IgA demonstrates that dot-ELISA using OMCs from 
N. meningitidis B as a target is suitable for serologic verification of clinically suspected meningococ-
cal disease in patients and for titer determination of antibodies produced during different phases 
of natural infection. Furthermore, the sensitivity of dot-ELISA was comparable to that of standard 
ELISA. Overall, dot-ELISA is simple to perform, rapid, and low cost. Further validation of the test as 
a screening tool is required.
Keywords: Neisseria meningitidis, dot-ELISA, ELISA, antibodies, outer membrane complex.
[Braz J Infect Dis 2010;14(1):35-40]©Elsevier Editora Ltda.
Comparison of dot-ELISA and standard ELISA for detection of  
Neisseria meningitidis outer membrane complex–specific antibodies
INTRODUCTION 
Bacterial meningitis remains a serious threat 
to global health and annually accounts for an 
estimated 170,000 deaths worldwide. Even 
with the availability of antimicrobial therapy 
and sophisticated intensive care, the case fa-
tality rate remains 5-10% in industrialized 
countries and is even higher in the develop-
ing world. Between 10-20% of survivors de-
velop permanent sequelae, such as epilepsy, 
mental retardation, or sense-neural deaf-
ness. Three species (Haemophilus influen-
zae, Streptococcus pneumoniae, and Neisseria 
meningitidis) are responsible for most cases 
of bacterial meningitis that occur after the 
neonatal period. Since the introduction of 
H. influenzae type b (Hib) conjugate vaccine, 
N. meningitidis and S. pneumoniae have be-
come the most common cause of bacterial 
meningitis in the world. Moreover, N. menin-
gitidis is the only bacterium capable of gener-
ating epidemics of meningitis.1
Between 2000 and 2006, there were 74,449 
reported cases of meningitis in the state of 
São Paulo; however, the microbiological eti-
ology was determined in only 24.7% of these 
cases. Among these, 8,710 cases (11.7%) 
were diagnosed with meningococcal men-
ingitis, 3,497 (4.7%) with pneumococcal 
meningitis, and 489 (0.6%) with menin-
gitis caused by Hib. An additional 14,990 
cases (20%) were considered to be possibly 
caused by a bacterial infection; however the 
etiologic agent was not identified.2
Dot-ELISA has been used to detect a va-
riety of bacterial and protozoal antigens.3-6 
Coll et al., 1998, developed a dot-ELISA that 
uses monoclonal antibodies for detection of 
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serogroup B meningococcal antigens in cerebrospinal 
fluid that has become a valuable tool in the detection of 
meningococci. Furthermore, in 1989 Oprandy & Sippel7 
used a monoclonal antibody that was immobilized on a 
nitrocellulose membrane for an antigen capture assay. 
The detection of a N. meningitidis serogroup A polysac-
charide using this assay was more sensitive than enzyme-
based immunoassays.7 Dot-ELISA using meningococcal 
outer membrane complexes (OMCs) as the antigen has 
been developed and used to investigate the isotypes of 
antibodies produced in patients with meningococcal dis-
ease caused by serogroup B. However, dot-ELISA using the 
outer membrane complex has not been evaluated for anti-
bodies detection of in human serum from patients infected 
with N. meningitidis. Therefore, the present study was con-
ducted to standardize and evaluate dot-ELISA in order to 
establish the optimal conditions for the detection of N. men-
ingitidis-specific IgG, IgM, and IgA in sera during natural 
infection. Dot-ELISA was compared with standard ELISA.
MATERIAL AND METHODS 
Clinical samples 
A total of 35 serum samples from 15 individuals with a 
clinical diagnosis of bacterial meningitis were analyzed. 
The clinical diagnosis was made on the basis of symp-
toms including fever, headache, vomiting, neck muscle 
rigidity, cerebral dysfunction, and toxemia.8,9 The cere-
brospinal fluid (CSF) samples were assayed using coun-
terimmunoelectrophoresis (CIE) in the Immunology 
Section of the Adolfo Lutz Institute. CSF was collected 
for immunodiagnosis and bacterial culture according to 
the standard technique, as previously described.10,11
Counterimmunoelectrophoresis 
CIE was performed on cellulose strips (Cellogel; Chemet-
ron, Italy) that had been stored in a 40% methanol so-
lution.11 Before use, the strips were washed in 0.05 
M sodium veronal buffer, pH 8.6 (Merck, Rio de Ja-
neiro) and dried between filter papers. For each test, 
7 μL of antiserum was applied at the anode and 10 μL of the 
treated sample was applied at the cathode, with the sample 
wells 0.6 cm apart. CIE was carried out for 10 min with a 
15-20 mA electric current using sodium veronal buffer. Af-
ter electrophoresis, the strips were washed six times for 10 
min in 0.15 M NaCl, stained in 50% methanol containing 
0.5% (w/v) amido black, and destained in 50% methanol 
containing 5% (v/v) acetic acid.
Bacterial culture
All CSF samples were cultured for bacterial growth and 
for serotyping at the Bacteriology Section of Adolfo Lutz 
Institute.12 Serum samples were collected from patients 
in the acute phase of the disease (upon admission to the 
hospital; day 0), during the convalescent phase (day 10), 
and during the late convalescent phase (4 weeks).8,9 All 
of the serum samples were collected in 1998 and were 
stored at -70° C until use. To determine the specificity 
and cross-reactivity of the tests, 12 samples obtained 
from patients in the acute phase of Haemophilus influen-
zae b infection and 10 samples from healthy individuals 
were also examined. A N. meningitidis outer membrane 
complex from strain B:4.19:P1.15,3,7,9, which was iso-
lated from the cerebrospinal fluid of a patient infected in 
the 1998 Brazilian epidemic, was used as antigen source. 
Since 1986, serogroup B N meningitidis has been re-
sponsible for approximately 80% of the meningococcal 
disease in Brazil.13 The serotype was determined in the 
Bacteriological Section of Adolfo Lutz Institute. Bacte-
ria were grown on brain heart infusion agar, and 10 mL 
of the culture was transferred to 500 mL of tryptic soy 
broth (Difco Laboratories, Detroit, MI) and incubated 
at 37° C in a rotary shaker (120 rpm) for 18 hours. 
Isolation of outer membrane complex 
The bacteria were harvested by centrifugation at 10,000´g 
for 15 min. The outer membrane complexes were ex-
tracted in 5 mL of buffer solution (0.1 M sodium acetate 
and 0.2 M LiCl, pH 5.8) per gram of cells (wet weight) 
by shaking with 2 mm diameter glass beads in a gyratory 
water bath at 45° C for 2 hours.14 The purified OMCs 
was obtained by removing cells by centrifugation at 
12,000 g for 20 min. The supernatant was dialyzed over-
night in 0.15 M NaCl, and protein concentration was 
determined as previously described.15
SDS-PAGE and by immunoblot 
The antigen used in dot-ELISA was analyzed by SDS-
PAGE in a 13% acrylamide gel, as described.16 Approxi-
mately 20 μg of the OMC antigen was stained with 
Coomassie brilliant blue, and 2 μg was used for lipopol-
ysaccharide determination (detected by silver staining), 
as described .17
The murine monoclonal antibodies against LPS deter-
minants (WBE12-C10-C10, L3,7,9-specific; 6E7-10, L8-
specific; and 3G3-1-8C, L1-specific; all generously supplied 
by Dr. Zollinger, Walter Reed Army Institute of Research, 
Washington, DC) were used to analyze the immunotypes 
present in the strains isolated from the 15 patients. Based 
on the antigenicity of the LPS, N. meningitidis can be di-
vided into 12 immunotypes. Immunotypes L1 to L8 
were found among the Group B and C strains18,19 and 
immunotypes L9 to L12 were in the Group A strains.20,21 
The apparent molecular weight of the separate cell com-
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ponents was determined by comparing their migration 
with those of molecular weight markers (Pharmacia, 
Uppsala, Sweden).
Dot-ELISA 
The membrane antigen–specific antibody titer was 
quantified using an enzymatic dot-ELISA. All opera-
tions were carried out at room temperature and all in-
cubations were performed on a shaking platform to pro-
vide gentle agitation. A nitrocellulose membrane (BioRad, 
Richmond, CA) was cut to fit the top of a 96-well plate and 
1 μL of the OMCs sample (0.21–0.84 μg) was carefully placed 
as a dot on the membrane in a position corresponding to 
the center of each well. The nitrocellulose membrane was 
blocked with 5% nonfat dry milk in TBS (0.01 M Tris-HCl, 
0.14 M NaCl). This solution was pre-heated in a 100°C water 
bath for 5 min to inactivate the endogenous milk proteases 
and then filtered. In previous experiments, we optimized the 
incubation time with blocking solution: no differences in 
background reactivity were seen when the blocking solution 
was incubated for 1 hour, 2 hours, or overnight. After block-
ing the membranes, 100 μL of serum samples serially diluted 
in 2.5% nonfat milk in TBS were added to each well and in-
cubated for 2 hours. The nitrocellulose membrane was blot-
ted in order to remove excess moisture and placed on the 
microtiter plate. The nitrocellulose membrane was sealed 
with a layer of parafilm by rolling a pipet across the sur-
face. Sheets of Whatman 3 MM paper were added, and the 
lid was clamped down with spring-type clamps. At the end 
of the first incubation, the nitrocellulose membrane was re-
moved and rapidly washed in PBS with 0.05% NP-40 (Shell 
Química do Brasil, São Paulo, Brazil) for 1 min with shaking 
and then washed in several changes of the same buffer for 30 
min. The washing solution was removed and 50 μL of diluted 
horseradish peroxidase–conjugated anti-human IgG, IgM, 
or IgA antibody (Sigma, St Louis, MO) were added to each 
well and incubated for 2 hours. The optimum dilution of 
the secondary antibody was found to be 1:500 for anti-IgG, 
1:1000 for anti-IgM, and 1:500 for anti-IgA. The conditions 
of the secondary antibody preparation and evaluation have 
been described previously.22 The secondary antibody was re-
moved and the membrane was washed as described above. 
The chromogen 4-chloro-1-naphthol (Sigma) was dissolved 
in a (stock solution, 3 mg/mL; Merck, Darmstadt, Germany) 
and stored in a dark bottle at room temperature for up to 
10 days. Immediately before use, 10 mL of PBS, 10 μL of 
30% H
2
O
2
, and 2 mL of the chromogen stock solution were 
mixed together and incubated for 20 min. The chromogen 
solution was removed and the membrane was washed, as de-
scribed above. Samples, in which blue dots developed, when 
compared with the negative control sera and the antigen and 
secondary antibody controls, were considered to be positive. 
The optimal antigen concentration for dot-ELISA was de-
termined using three concentrations of antigens (0.21, 0.42, 
and 0.84 μg/dot) and tested with positive sera and negative 
control sera.
ELISA 
A standard ELISA was performed for meningo-
coccal-specific antibodies. The OMCs from strain 
B:4.19:P1.15,3,7,9 was plated in triplicate in microdilu-
tion plates (Nunc), as described by Harthug et al.23 with 
some modification. A polystyrene immunoplate (Nunc) 
with 96 wells was coated with 100 uL of OMCs per well, 
corresponding to 2 ug of protein per mL in 0.1 M Tris 
buffer, pH 8.5, and incubated for 18 hours. All incuba-
tions were performed at 37° C. The plates were stored 
at 4° C for up to 2 weeks and were washed four times in 
phosphate-buffered saline, pH 7.4, with 0.05% Tween 20 
and 0.02% sodium azide immediately before use. Two 
serum samples that showed strong immune responses to 
OMCs antigens were used as internal standards. All se-
rum samples were diluted 1:200 in phosphate-buffered 
saline, pH 7.4, with 0.05% Tween 20, 0.1% bovine serum 
albumin, and 0.02% sodium azide and analyzed in trip-
licate. Diluted serum (100 μL) was added to each well, 
incubated for 3 hours, and then washed as described 
above. A horseradish peroxidase–conjugated goat anti-
human IgA, IgM, or IgG (Sigma Chemical Co., St Louis, 
MO) detection system was used to detect the bound 
antibodies. Incubations were carried out at 37º C for 1 
hour in all steps, except for that with the substrate (15 
min). The reaction was interrupted with 4 N H2SO4. 
The absorbance was obtained at 450 nm in a plate reader 
(SLT-Spectra, US).
RESULTS
The electrophoretic profile of the N. meningitidis anti-
gens (both protein and lipopolysaccharide) used in the 
assay is shown in Figure 1A. The proteins are mainly 20 
to 120 kDa in weight and the expression of L3,7 determi-
nants could be seen when monoclonal antibodies were 
used.24 We tested the serum from patients with clinically 
and laboratory proven N. meningitidis serotype B and 
healthy individuals using the dot-ELISA (Figure 1B). 
Positive reactions (blue dots) developed against anti-
gens spots that were incubated with dilutions of serum 
from patients with N. meningitidis serotype B, whereas 
spots incubated with the serum from healthy individu-
als were negative or below the cut-off for IgG, IgM, or 
IgA. To test the reproducibility of dot-ELISA for detec-
tion of antigen-specific IgG, IgM, and IgA each serum 
sample was tested in duplicate against meningococcal 
antigens, and the optimal agreement between duplicates 
was obtained. The mean level of antigen-specific IgG, 
IgM, and IgA were significantly higher in patients with 
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Figure 1: 
(A) The SDS-PAGE of the native outer membrane complex of 
representative N. meningitidis B strains isolated from patients 
are shown in lanes 1, 4, 7, and 10 after Coomassie blue staining. 
Lanes 2, 5, 8, and 11 demonstrate the analysis of LPS variants 
by PAGE and silver staining, and lanes 3,6,9, and 12 are 
immunoblots. The immunoblots were sequentially reacted with 
three different monoclonal antibodies. The band at position 
(a), (b), and (c) reacted with the WBE12-C10 (L3,7,9-specific; 5.9 
kDa), the 3G3-1-8C (L1-specific; 4.8 kDa), and the 6E7-10 (L8-
specific; 3.6 kDa) monoclonal antibody, respectively. The outer 
membrane complex of the strain) B:4.19:P1.15,3,7,9 shown in 
lanes 1 was used in the dot-ELISA and the ELISA assay.
(B) Dot-ELISA for the detection of N. meningitis B outer 
membrane complex–specific IgG in patient serum at a 1:100 
(A) to 1:12,800 (H) dilution demonstrating the sensitivity of the 
assay. For each spot, 0.42 µg of the OMC was spotted onto 
a nitrocellulose membrane. Lanes 1 through 10 demonstrate 
the immunoreactivity of patient serum in different phases of 
the disease. Serum samples were collected from patients in the 
acute phase (upon admission to the hospital; day 0), during the 
convalescent phase (day 10), and during the late convalescent 
phase (4 weeks). Lanes 11 and 12 are serum samples from 
normal controls. The color intensity was judged visually, and 
the intensities were assigned values on an arbitrary scale (0, +, 
++, +++, or ++++) in reference to the negative control (assigned 
a value of 0).The dots are blue in color.
Table 1. Performance of assays for detecting antibodies in this sample studies
             A- ElISA
Isotypes Cut-off titer Sensitivity* Sensitivity* Preditive Value             Efficiency
    positive negative
IgG 1:200 98.1 98.5 89.1 93.5 91.9
IgM 1:200 86.4 100 100 92.2 94.9
IgA 1:100 89.1 100 100 93.9 95.9
                ElISA
IgG 1:100 91.9 100 100 99.9 83.8
IgM 1:100 92.3 100 100 100 93.8
IgA 1:100 88.3 100 100 95.3 99.7
*(%)
B - Comparison between Standard ElISA IgG absorbance and dot-ElISA positivity
Dot-ElISA ElISA samples Tested
Scale A 492nm
+4 1.87-1.68 10
+3 1.00-1.12 10
+2 0.80-0.65 10
+1 0.36-0.55 5
0  0.05-0.34  0
active meningitis than in normal subjects. The reactiv-
ity of several standard positive and negative control se-
rum samples for meningococcal antigens (0.42 μg anti-
gens) suggested the possibility of using serum samples 
diluted more than 1:100. Importantly, while the serum 
samples from patients with H. influenzae b presented 
cross-reactivity, this cross-reactivity decreased with the 
dilution of the serum samples. As seen in Table 1A, the 
IgM and IgA presented a lower degree of cross-reactivity 
when compared with the IgG in the same serum sample. 
Comparison of dot-ELISA and standard Neisseria meningitidis detection
A
B
  1    2     3      4    5    6     7    8     9   10  11  12
12    11   10    9      8      7    6      5    4      3      2     1
A
B
C
D
E
F
G
H
a
b
c
94
64
43
30
20
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To obtain a higher efficiency for dot-ELISA, cut-off val-
ues were selected to better discriminate between men-
ingitis patients and the normal controls (Table 1A). 
Furthermore, the longitudinal titer of the different an-
tibody isotypes during the course of meningococcal in-
fection was determined. The IgG titer was low at admis-
sion (p < 0.05) and increased progressively thereafter. 
IgM titer was greater than IgG titer and also increased in 
later stages of infection. IgA titer was higher than aver-
age during early convalescence (p < 0.05) and decreased 
during the convalescent stage. The color intensity was 
judged visually, and the intensities were assigned values 
on an arbitrary scale (0, +, ++, +++, or ++++) in refer-
ence to the negative control (assigned a value of 0). For 
determination of the sensitivity, specificity, and positive and 
negative predictive values of dot-ELISA, a standard ELISA 
was carried out and analyzed. Our results demonstrated a 
good correlation between the visual grading of dot-ELISA 
and ELISA absorbance (Table 1B).
The antibodies measured in this study were most likely 
directed against the 20–120 kDa proteins and the L3,7 LPS 
date not shown. 
 
DISCUSSION 
LPS is an important component of the outer membrane of 
meningococcal bacteria. Neisseria produces one to six differ-
ent LPS molecules (3,200 to 7,200 Da) that can be character-
ized by their electrophoretic mobility in SDS-PAGE.22 The 
difference in mobility appears to be due to the heterogeneity 
of the chemical composition of oligosaccharides. Antibodies 
directed against strain-specific epitopes and different outer 
membrane proteins of N. meningitidis B have been detected 
in serum from convalescent patients.5,6 In this study, a dot-
ELISA using the OMCs derived from N. meningitidis sero-
type B was found to be a specific technique for establishing 
the level of antigen-specific IgG, IgM, and IgA present in 
serum of patients during the different stages of infection. It 
also has technical advantages, such as at the use of minute 
amounts of antigens, antibody conjugates, and a chromog-
enic solution. 
The procedure of dot-ELISA has a number of advan-
tages over the standard ELISA currently performed in labo-
ratory. The nitrocellulose membrane is capable of binding 
more antigens than the microtiter plates.25 Therefore, only 
a small amount of the OMCs is required as an antigen for 
the test. Additionally, the reaction on nitrocellulose mem-
brane is viewed against the membrane white background, 
making it much easier to identify a positive or negative re-
action. Another advantage of dot-ELISA is that it does not 
require spectrophotometric readings, which are required in 
classic plate- or cuvette-based ELISAs, an important consid-
eration for laboratories in developing countries. Most im-
munologic assays, including the dot-ELISA, are influenced 
by both the antibody concentration and affinity. However, 
dot-ELISA appears to be one of the more sensitive and least 
affinity-dependent procedures.3 In contrast with antibody 
response against serotype B polysaccharide, which has been 
shown to be mediated mostly by IgM, the response against 
the OMCs antigens using dot-ELISA seems to be mediated 
by other isotypes, such as IgG and IgA. This assay was also 
useful in the longitudinal analysis of the antigen-specific 
immunoglobulin titers for use in immunological studies of 
this severe disease. OMC-specific IgM was detected in all 
N. meningitidis patients, without any H. influenzae b cross-
reactivity. This suggests that this assay will be suitable for use 
in hospital laboratories, especially when the bacterial culture 
of CSF samples produce a negative result. Application of this 
technique in patient diagnosis and screening is valid because 
of the test easy execution and the characteristics described 
above. The sensitivity of dot-ELISA and standard ELISA was 
similar, as previously reported.26 Dot-ELISA could be used 
for screening meningococcal disease in less well-equipped 
laboratories. N. meningitidis-specific IgG, IgM, and IgA were 
detected in the serum from all 35 sera investigated using dot-
ELISA with good sensitivity. 
A multianalyte Dot-enzyme-linked immunosorbent as-
say (Dot-ELISA-Multi) with Trypanosoma cruzi epimastig-
ote alkaline extract (EAE), trypomastigote excreted–secreted 
antigen (TESA), recombinant protein derived from 19-kDa 
C-terminal region of the Plasmodium vivax merozoite sur-
face protein 1 (PvMSP119), Plasmodium falciparum Zwit-
tergentR extract (Pf-Zw), and Treponema pallidum Zwit-
tergentR extract (Tp-Zw) was standardize and evaluated as 
a method for surveying IgG-specific antibodies in Chagas 
disease, malaria, and syphilis in a single test.27 
In conclusion, dot-ELISA presented here is very useful 
and easy to handle; it uses minute amounts of antigen, can 
measure the level of antibodies IgG, IgM and IgA in Neisse-
ria meningitidis infection with facility, and the results can be 
seen directly by the naked eye.
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